Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Osteoporosis, Postmenopausal × Risedronic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Osteoporosis 9 Breast Neoplasms 6 Bone Diseases, Metabolic 5 Prostatic Neoplasms 4 Triple Negative Breast Neoplasms 1 Prostatic Hyperplasia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Osteoporosis, Postmenopausal 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Esophageal Neoplasms 1 Dwarfism, Pituitary 1 Carcinoma, Squamous Cell 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1 Adenocarcinoma 1

Interventions

Weights and Measures 1 Risedronic Acid 1 Resistance Training 1 LY 353381 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00567606 2023-11-30

Prevention of Osteoporosis in Breast Cancer Survivors

University of Nebraska

Phase NA Completed

Osteoporosis, Postmenopausal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡